On 1 October 2015, AMC will use ECFMG’s Electronic Portfolio of International Credentials (EPIC) service to verify International Medical Graduate’s (IMGs) medical credentials for registration purposes with the Medical Board of Australia, and for specialist assessment by an Australian Medical College. Currently, AMC uses ECFMG’s International Credentials Services (EICS) for this purpose. EPIC will provide AMC with the same rigorous primary source verification that ECFMG provides through EICS while offering IMGs additional benefits not available through EICS.
Throughout the year Independent Grants for Learning & Change (IGLC) may send out communications directly to registered users of the Pfizer Grant Management System (GMS) with regard to important and time-sensitive topics (., change in policy, changes in process or procedures, system enhancements). Such communications are posted below for your reference in descending chronological order. In addition to announcements prepared by IGLC, posted below you will find other relevant information we wish to share with our stakeholder community.
The concept of non-maleficence is embodied by the phrase, "first, do no harm," or the Latin, primum non nocere . Many consider that should be the main or primary consideration (hence primum ): that it is more important not to harm your patient, than to do them good. This is partly because enthusiastic practitioners are prone to using treatments that they believe will do good, without first having evaluated them adequately to ensure they do no (or only acceptable levels of) harm. Much harm has been done to patients as a result, as in the saying, "The treatment was a success, but the patient died." It is not only more important to do no harm than to do good; it is also important to know how likely it is that your treatment will harm a patient. So a physician should go further than not prescribing medications they know to be harmful—he or she should not prescribe medications (or otherwise treat the patient) unless s/he knows that the treatment is unlikely to be harmful; or at the very least, that patient understands the risks and benefits, and that the likely benefits outweigh the likely risks.